Mayne Pharma Group (MAYNF) Stock Price, News & Analysis

Company Overview

Mayne Pharma Group Limited is an Australia-based specialty pharmaceutical company that develops, manufactures, and commercializes branded and generic prescription medicines. Its activities include product development, regulatory support, manufacturing, and the distribution of pharmaceutical products through its own commercial operations and external partners.

The company has focused on therapeutic areas including dermatology, women’s health, and other specialty-care markets. Its portfolio has included prescription products such as oral and topical medicines, as well as contraceptive and other branded therapies. Mayne Pharma has also provided contract development and manufacturing services for pharmaceutical companies.

Mayne Pharma was established as an independent pharmaceutical business following its separation from Mayne Nickless in 2002. The company has served customers in Australia and international markets, with a significant commercial presence in the United States. Its products have been marketed through a combination of direct sales, licensing arrangements, and strategic partnerships.

Key Stats

• Today's Range: $1.87 to $1.87
• 50-Day Range: $1.65 to $2.37
• 52-Week Range: $1.40 to $3.90
• Volume: N/A
• Average Volume: 3,628 shs
• Market Capitalization: N/A
• P/E Ratio: 51.94
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

Mayne Pharma Group Stock Analysis - MarketRank™

Mayne Pharma Group scored higher than 0% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: N/A
• Analyst Rating: N/A

Consensus Rating

There is not enough analysis data for Mayne Pharma Group.

Earnings and Valuation

• Score: 0.0 / 5
• Proj. Earnings Growth: N/A

Price to Earnings Ratio vs. the Market

The P/E ratio of Mayne Pharma Group is 51.94, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 27.02.

Price to Earnings Ratio vs. Sector

The P/E ratio of Mayne Pharma Group is 51.94, which means that it is trading at a more expensive P/E ratio than the Healthcare sector average P/E ratio of about 36.88.

Short Interest

• Score: 2.0 / 5
• Short Interest Level: Bearish

Percentage of Shares Shorted

Short Interest Ratio / Days to Cover

Mayne Pharma Group has a short interest ratio ("days to cover") of 23.14, which indicates bearish sentiment.

Change versus previous month

Short interest in Mayne Pharma Group has recently decreased by 11.65%, indicating that investor sentiment is improving significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Mayne Pharma Group does not currently pay a dividend.

Dividend Growth

Mayne Pharma Group does not have a long track record of dividend growth.

News and Social Media

• Score: 0.0 / 5
• News Sentiment: 0.00

News Coverage This Week

MarketBeat has tracked 2 news articles for Mayne Pharma Group this week, compared to 0 articles on an average week.

Company Ownership

• Score: 0.2 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Mayne Pharma Group insiders have not sold or bought any company stock.

Percentage Held by Institutions

15.80% of the stock of Mayne Pharma Group is held by institutions.

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Healthcare
• Industry: Pharmaceuticals
• Sub-Industry: Pharmaceuticals
• Current Symbol: OTCMKTS:MAYNF
• CIK: N/A
• Web: www.maynepharma.com
• Phone: (188) 209-2666
• Fax: N/A
• Employees: 450
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: 51.94
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A